Dr Robin Carhart-Harris is Head of the Psychedelic Research Group at Imperial College London, where he has designed a number of pioneering brain imaging studies with psychedelic drugs such as psilocybin (magic mushrooms), LSD, MDMA (ecstasy) and DMT (ayahuasca), plus a clinical trial of psilocybin for treatment resistant depression. In 2018 he Co-Founded a new psychedelic research charity Global Psychedelic Research (globalpsychedelicresearch.org) to raise funds for research on naturally occurring (classic) psychedelic compounds.
